YBX1 and idiopathic pulmonary fibrosis: From a mechanistic perspective, activation of YBX1 by Omaveloxolone could help preserve AT2 cell homeostasis by improving mitochondrial integrity, reducing oxidative stress, and preventing apoptosis—processes previously linked to epithelial injury in IPF.